These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048. Kuca K, Cabal J. Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981 [Abstract] [Full Text] [Related]
5. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications. Kuca K, Bartosová L, Jun D, Patocka J, Cabal J, Kassa J, Kunesová G. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):75-82. PubMed ID: 16170392 [Abstract] [Full Text] [Related]
7. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Calić M, Vrdoljak AL, Radić B, Jelić D, Jun D, Kuca K, Kovarik Z. Toxicology; 2006 Feb 15; 219(1-3):85-96. PubMed ID: 16332406 [Abstract] [Full Text] [Related]
9. Reactivation of organophosphate-inhibited acetylcholinesterase by quaternary pyridinium aldoximes. Kuca K, Patocka J, Cabal J, Jun D. Neurotox Res; 2004 Feb 15; 6(7-8):565-70. PubMed ID: 15639788 [Abstract] [Full Text] [Related]
10. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats. Kassa J, Jun D, Kuca K. J Enzyme Inhib Med Chem; 2007 Jun 15; 22(3):297-300. PubMed ID: 17674811 [Abstract] [Full Text] [Related]
11. In vitro reactivation of acetylcholinesterase using the oxime K027. Kuca K, Kassa J. Vet Hum Toxicol; 2004 Feb 15; 46(1):15-8. PubMed ID: 14748409 [Abstract] [Full Text] [Related]
12. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases. Kuca K, Cabal J, Jun D, Musilek K. Neurotox Res; 2007 Feb 15; 11(2):101-6. PubMed ID: 17449453 [Abstract] [Full Text] [Related]
15. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Kassa J, Cabal J. Hum Exp Toxicol; 1999 Sep 15; 18(9):560-5. PubMed ID: 10523870 [Abstract] [Full Text] [Related]
16. A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods. Kuca K, Cabal J, Kassa J. J Toxicol Environ Health A; 2005 Apr 23; 68(8):677-86. PubMed ID: 15901095 [Abstract] [Full Text] [Related]
17. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J, Karasova JZ, Pavlikova R, Musilek K, Kuca K, Bajgar J, Jung YS. Toxicol Mech Methods; 2011 Mar 23; 21(3):241-5. PubMed ID: 21142778 [Abstract] [Full Text] [Related]
18. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain. Kuca K, Cabal J, Kassa J, Jun D, Hrabinová M. J Appl Toxicol; 2005 Mar 23; 25(4):271-6. PubMed ID: 16021679 [Abstract] [Full Text] [Related]
19. Potency of novel oximes to reactivate sarin inhibited human cholinesterases. Jun D, Kuca K, Picha J, Koleckar V, Marek J. Drug Chem Toxicol; 2008 Mar 23; 31(1):1-9. PubMed ID: 18161504 [Abstract] [Full Text] [Related]
20. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice. Kassa J, Sepsova V, Matouskova L, Horova A, Musilek K. Toxicol Mech Methods; 2015 Mar 23; 25(3):229-33. PubMed ID: 25894563 [Abstract] [Full Text] [Related] Page: [Next] [New Search]